Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Eris Lifesciences Limited
  6. News
  7. Summary
    540596   INE406M01024

ERIS LIFESCIENCES LIMITED

(540596)
  Report
End-of-day quote Bombay Stock Exchange  -  2022-09-29
710.90 INR   +1.10%
09/09Eris Lifesciences : ESOP/ESPS/SBEB Scheme
PU
08/25Eris Lifesciences Seeks Acquisitions
CI
08/05Eris Lifesciences Limited Provides Revenue Guidance for the Year 2023
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Eris Lifesciences Limited Provides Revenue Guidance for the Year 2023

08/05/2022 | 06:30am EDT

Eris Lifesciences Limited provided revenue guidance for the year 2023. For the year, the company is targeted a consolidated revenue growth of 30%.


© S&P Capital IQ 2022
All news about ERIS LIFESCIENCES LIMITED
09/09Eris Lifesciences : ESOP/ESPS/SBEB Scheme
PU
08/25Eris Lifesciences Seeks Acquisitions
CI
08/05Eris Lifesciences Limited Provides Revenue Guidance for the Year 2023
CI
08/05Transcript : Eris Lifesciences Limited, Q1 2023 Earnings Call, Aug 05, 2022
CI
08/05Eris Lifesciences Limited Declares Interim Dividend for the Financial Year 2022-2023, P..
CI
08/05Eris Lifesciences Limited Reports Earnings Results for the First Quarter Ended June 30,..
CI
08/02Eris Lifesciences Board to Consider Interim Dividend for Fiscal 2023
MT
07/20Eris Lifesciences : Resignation
PU
07/20Eris Lifesciences Limited Announces Resignation of Vijaya Sampath as Independent Direct..
CI
07/18Eris Lifesciences : Schedule of Analysts/Institutional Investor Meet/Con. Call
PU
More news
Financials
Sales 2023 17 276 M 212 M 212 M
Net income 2023 4 213 M 51,8 M 51,8 M
Net Debt 2023 4 214 M 51,8 M 51,8 M
P/E ratio 2023 23,0x
Yield 2023 0,96%
Capitalization 96 676 M 1 188 M 1 188 M
EV / Sales 2023 5,84x
EV / Sales 2024 4,91x
Nbr of Employees 3 400
Free-Float 21,2%
Chart ERIS LIFESCIENCES LIMITED
Duration : Period :
Eris Lifesciences Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ERIS LIFESCIENCES LIMITED
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 710,90 INR
Average target price 858,33 INR
Spread / Average Target 20,7%
EPS Revisions
Managers and Directors
Amit Indubhushan Bakshi Chairman & Managing Director
Vijay S. Joshi President
Sachin Shah Senior Manager-Finance & Processes
Krishnakumar Vaidyanathan Chief Operating Officer & Executive Director
Milind Talegaonkar Secretary & Compliance Officer
Sector and Competitors
1st jan.Capi. (M$)
ERIS LIFESCIENCES LIMITED-6.32%1 188
JOHNSON & JOHNSON-4.51%429 503
ELI LILLY AND COMPANY19.47%307 239
ROCHE HOLDING AG-14.68%271 055
PFIZER, INC.-25.89%245 597
ABBVIE INC.-0.88%237 296